Jane Street’s Exact Sciences EXAS Stock Holding History

Jane Street’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-55,100	Closed	-$5.6M	–	11956
2025 Q4	$5.6M	Sell	55,100 -27,500	-33%	-$2.21M	﹤0.01%	3059
2025 Q3	$4.52M	Sell	82,600 -8,800	-10%	-$440K	﹤0.01%	3571
2025 Q2	$4.86M	Sell	91,400 -10,200	-10%	-$518K	﹤0.01%	3036
2025 Q1	$4.4M	Sell	101,600 -369,500	-78%	-$18.7M	﹤0.01%	3118
2024 Q4	$26.5M	Buy	471,100 +138,900	+42%	+$8.64M	0.01%	1072
2024 Q3	$22.6M	Buy	332,200 +182,500	+122%	+$10.3M	0.01%	1153
2024 Q2	$6.32M	Sell	149,700 -171,200	-53%	-$9.42M	﹤0.01%	2630
2024 Q1	$22.2M	Buy	320,900 +185,300	+137%	+$11.7M	﹤0.01%	1111
2023 Q4	$10M	Sell	135,600 -8,100	-6%	-$531K	﹤0.01%	1954
2023 Q3	$9.8M	Sell	143,700 -136,800	-49%	-$11.6M	﹤0.01%	1796
2023 Q2	$26.3M	Buy	280,500 +211,600	+307%	+$16.5M	0.01%	981
2023 Q1	$4.67M	Sell	68,900 -72,400	-51%	-$4.65M	﹤0.01%	2554
2022 Q4	$7M	Sell	141,300 -12,100	-8%	-$494K	﹤0.01%	2045
2022 Q3	$4.98M	Buy	153,400 +10,700	+7%	+$441K	﹤0.01%	2619
2022 Q2	$5.62M	Buy	142,700 +300	+0.2%	+$16K	﹤0.01%	2495
2022 Q1	$9.96M	Buy	142,400 +38,700	+37%	+$2.83M	﹤0.01%	1997
2021 Q4	$8.07M	Sell	103,700 -11,100	-10%	-$980K	﹤0.01%	2158
2021 Q3	$11M	Sell	114,800 -18,600	-14%	-$1.96M	﹤0.01%	1700
2021 Q2	$16.6M	Buy	133,400 +9,900	+8%	+$1.18M	0.01%	1243
2021 Q1	$16.3M	Sell	123,500 -64,000	-34%	-$8.76M	0.01%	1150
2020 Q4	$24.8M	Buy	187,500 +8,500	+5%	+$1.03M	0.01%	738
2020 Q3	$18.2M	Sell	179,000 -54,900	-23%	-$4.74M	0.01%	831
2020 Q2	$20.3M	Buy	233,900 +90,900	+64%	+$7.26M	0.02%	746
2020 Q1	$8.29M	Sell	143,000 -63,600	-31%	-$5.16M	0.01%	866
2019 Q4	$19.1M	Buy	206,600 +139,300	+207%	+$12.2M	0.03%	395
2019 Q3	$6.08M	Buy	67,300 +17,700	+36%	+$2.02M	0.01%	855
2019 Q2	$5.86M	Buy	49,600 +1,000	+2%	+$101K	0.01%	940
2019 Q1	$4.21M	Sell	48,600 -170,300	-78%	-$14.5M	0.01%	1281
2018 Q4	$13.8M	Buy	218,900 +147,400	+206%	+$10.1M	0.03%	438
2018 Q3	$5.64M	Sell	71,500 -10,100	-12%	-$659K	0.01%	952
2018 Q2	$4.88M	Buy	81,600 +25,900	+46%	+$1.39M	0.01%	1063
2018 Q1	$2.25M	Sell	55,700 -2,800	-5%	-$137K	0.01%	1711
2017 Q4	$3.07M	Sell	58,500 -11,400	-16%	-$609K	0.01%	1209
2017 Q3	$3.29M	Sell	69,900 -33,700	-33%	-$1.36M	0.01%	1170
2017 Q2	$3.66M	Buy	103,600 +14,900	+17%	+$460K	0.01%	977
2017 Q1	$2.1M	Buy	88,700 +72,700	+454%	+$1.44M	0.01%	1337
2016 Q4	$214K	Sell	16,000 -24,900	-61%	-$402K	﹤0.01%	3682
2016 Q3	$760K	Buy	40,900 +17,400	+74%	+$307K	﹤0.01%	2289
2016 Q2	$288K	Buy	23,500 +13,100	+126%	+$98.7K	﹤0.01%	3370
2016 Q1	$70K	Buy	+10,400	New	+$66.5K	﹤0.01%	3934

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Jane Street's EXAS Position: Q1 2026 in Review

Jane Street sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,428,305 shares — an estimated $145M sold.

Jane Street first reported a position in EXAS in Q2 2013 and held it in 45 quarters. The position peaked at $145M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Jane Street reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Jane Street sold 1,428,305 Exact Sciences shares in Q1 2026, an estimated $145M.
Jane Street first reported a position in Exact Sciences in Q2 2013 and held it in 45 quarters.
Jane Street's Exact Sciences position peaked at $145M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.